• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊维菌素:从抗病毒作用到 COVID-19 补充治疗方案的系统评价。

Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen.

机构信息

Head of Ophthalmology Division, Taleghani Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Kish International Campus, University of Tehran, Tehran, Iran.

出版信息

J Antibiot (Tokyo). 2020 Sep;73(9):593-602. doi: 10.1038/s41429-020-0336-z. Epub 2020 Jun 12.

DOI:10.1038/s41429-020-0336-z
PMID:32533071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7290143/
Abstract

Ivermectin proposes many potentials effects to treat a range of diseases, with its antimicrobial, antiviral, and anti-cancer properties as a wonder drug. It is highly effective against many microorganisms including some viruses. In this comprehensive systematic review, antiviral effects of ivermectin are summarized including in vitro and in vivo studies over the past 50 years. Several studies reported antiviral effects of ivermectin on RNA viruses such as Zika, dengue, yellow fever, West Nile, Hendra, Newcastle, Venezuelan equine encephalitis, chikungunya, Semliki Forest, Sindbis, Avian influenza A, Porcine Reproductive and Respiratory Syndrome, Human immunodeficiency virus type 1, and severe acute respiratory syndrome coronavirus 2. Furthermore, there are some studies showing antiviral effects of ivermectin against DNA viruses such as Equine herpes type 1, BK polyomavirus, pseudorabies, porcine circovirus 2, and bovine herpesvirus 1. Ivermectin plays a role in several biological mechanisms, therefore it could serve as a potential candidate in the treatment of a wide range of viruses including COVID-19 as well as other types of positive-sense single-stranded RNA viruses. In vivo studies of animal models revealed a broad range of antiviral effects of ivermectin, however, clinical trials are necessary to appraise the potential efficacy of ivermectin in clinical setting.

摘要

伊维菌素具有多种潜在的治疗作用,具有抗微生物、抗病毒和抗癌特性,堪称“神药”。它对许多微生物,包括一些病毒,都具有高度的有效性。在本次全面的系统综述中,总结了过去 50 年来伊维菌素的抗病毒作用,包括体外和体内研究。有几项研究报告了伊维菌素对 RNA 病毒(如寨卡病毒、登革热病毒、黄热病病毒、西尼罗河病毒、亨德拉病毒、新城疫病毒、委内瑞拉马脑炎病毒、基孔肯雅热病毒、塞姆利基森林病毒、辛德毕斯病毒、禽流感病毒 A、猪繁殖与呼吸综合征病毒、人类免疫缺陷病毒 1 和严重急性呼吸综合征冠状病毒 2)的抗病毒作用。此外,还有一些研究表明伊维菌素对 DNA 病毒(如马疱疹病毒 1、BK 多瘤病毒、伪狂犬病病毒、猪圆环病毒 2 和牛疱疹病毒 1)具有抗病毒作用。伊维菌素在几种生物学机制中发挥作用,因此它可能成为治疗范围广泛的病毒的潜在候选药物,包括 COVID-19 以及其他类型的正链单链 RNA 病毒。动物模型的体内研究表明伊维菌素具有广泛的抗病毒作用,但仍需临床试验来评估伊维菌素在临床环境中的潜在疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc41/7290143/4474db36721f/41429_2020_336_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc41/7290143/4474db36721f/41429_2020_336_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc41/7290143/4474db36721f/41429_2020_336_Fig1_HTML.jpg

相似文献

1
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen.伊维菌素:从抗病毒作用到 COVID-19 补充治疗方案的系统评价。
J Antibiot (Tokyo). 2020 Sep;73(9):593-602. doi: 10.1038/s41429-020-0336-z. Epub 2020 Jun 12.
2
Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?伊维菌素作为一种广谱宿主导向抗病毒药物:真有那么神?
Cells. 2020 Sep 15;9(9):2100. doi: 10.3390/cells9092100.
3
The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?广谱宿主导向药物伊维菌素作为 SARS-CoV-2 的抗病毒药物?
Biochem Biophys Res Commun. 2021 Jan 29;538:163-172. doi: 10.1016/j.bbrc.2020.10.042. Epub 2020 Oct 21.
4
The Battle against COVID 19 Pandemic: What we Need to Know Before we "Test Fire" Ivermectin.抗击新冠疫情:在我们“试用”伊维菌素之前我们需要了解的事情。
Drug Res (Stuttg). 2020 Aug;70(8):337-340. doi: 10.1055/a-1185-8913. Epub 2020 Jun 19.
5
A systematic review of experimental evidence for antiviral effects of ivermectin and an in silico analysis of ivermectin's possible mode of action against SARS-CoV-2.伊维菌素抗病毒作用的实验证据的系统评价及伊维菌素对严重急性呼吸综合征冠状病毒2可能作用方式的计算机模拟分析。
Fundam Clin Pharmacol. 2021 Apr;35(2):260-276. doi: 10.1111/fcp.12644. Epub 2021 Jan 28.
6
Antivirals that target the host IMPα/β1-virus interface.靶向宿主 IMPα/β1-病毒界面的抗病毒药物。
Biochem Soc Trans. 2021 Feb 26;49(1):281-295. doi: 10.1042/BST20200568.
7
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.新型、强效二氢乳清酸脱氢酶(DHODH)抑制剂是广谱抗 RNA 病毒药物,可针对包括新型冠状病毒 SARS-CoV-2 在内的多种 RNA 病毒。
Protein Cell. 2020 Oct;11(10):723-739. doi: 10.1007/s13238-020-00768-w. Epub 2020 Aug 4.
8
Ivermectin also inhibits the replication of bovine respiratory viruses (BRSV, BPIV-3, BoHV-1, BCoV and BVDV) in vitro.伊维菌素还能抑制体外牛呼吸道病毒(BRSV、BPIV-3、BoHV-1、BCoV 和 BVDV)的复制。
Virus Res. 2021 May;297:198384. doi: 10.1016/j.virusres.2021.198384. Epub 2021 Mar 10.
9
Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment.定量蛋白质组学揭示了伊维菌素的广谱抗病毒特性,有利于 COVID-19 的治疗。
J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
10
Antiviral activity of hop constituents against a series of DNA and RNA viruses.啤酒花成分对一系列DNA和RNA病毒的抗病毒活性。
Antiviral Res. 2004 Jan;61(1):57-62. doi: 10.1016/s0166-3542(03)00155-4.

引用本文的文献

1
Advancements in antiviral approaches against foot-and-mouth disease virus: a comprehensive review.抗口蹄疫病毒抗病毒方法的进展:综述
Front Vet Sci. 2025 Jul 16;12:1574193. doi: 10.3389/fvets.2025.1574193. eCollection 2025.
2
Ivermectin's neuroprotective effects decrease with prolonged use after cerebral ischemia/reperfusion.伊维菌素在脑缺血/再灌注后长期使用时,其神经保护作用会降低。
Metab Brain Dis. 2025 Jun 25;40(6):234. doi: 10.1007/s11011-025-01657-z.
3
The impact of ivermectin on COVID-19 outcomes: a systematic review and meta-analysis.

本文引用的文献

1
COVID-19 and Ophthalmology: A New Chapter in an Old Story.新型冠状病毒肺炎与眼科:旧故事中的新篇章。
Med Hypothesis Discov Innov Ophthalmol. 2020 Summer;9(2):71-73. Epub 2020 Mar 4.
2
Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines.用于治疗新型冠状病毒肺炎的草药医学与辨证论治:指南快速回顾
Integr Med Res. 2020 Jun;9(2):100407. doi: 10.1016/j.imr.2020.100407. Epub 2020 Mar 29.
3
Metronidazole; a Potential Novel Addition to the COVID-19 Treatment Regimen.甲硝唑:新冠治疗方案中一种潜在的新添加药物。
伊维菌素对COVID-19结局的影响:一项系统评价和荟萃分析。
Ann Med Surg (Lond). 2025 Jan 7;87(2):809-829. doi: 10.1097/MS9.0000000000002762. eCollection 2025 Feb.
4
Clinical Experience With Ivermectin and Nitazoxanide in the Management of COVID-19 Among Mexican Out- and Inpatients.伊维菌素和硝唑尼特治疗墨西哥新冠门诊及住院患者的临床经验
Cureus. 2024 Nov 26;16(11):e74513. doi: 10.7759/cureus.74513. eCollection 2024 Nov.
5
Repositioning of Antibiotics in the Treatment of Viral Infections.抗生素在病毒感染治疗中的再定位。
Curr Microbiol. 2024 Oct 26;81(12):427. doi: 10.1007/s00284-024-03948-7.
6
Efficacy of Ivermectin, Chloroquine/Hydroxychloroquine, and Azithromycin in Managing COVID-19: A Systematic Review of Phase III Clinical Trials.伊维菌素、氯喹/羟氯喹及阿奇霉素治疗新冠肺炎的疗效:III期临床试验的系统评价
Biomedicines. 2024 Sep 27;12(10):2206. doi: 10.3390/biomedicines12102206.
7
Computational Drug Design Strategies for Fighting the COVID-19 Pandemic.计算药物设计策略对抗 COVID-19 大流行。
Adv Exp Med Biol. 2024;1457:199-214. doi: 10.1007/978-3-031-61939-7_11.
8
Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial.口服伊维菌素治疗轻至中度新型冠状病毒肺炎患者的疗效和安全性:一项多中心、双盲、随机对照临床试验。
BMC Infect Dis. 2024 Jul 22;24(1):719. doi: 10.1186/s12879-024-09563-y.
9
Antiviral Chemotherapy in Avian Medicine-A Review.禽医学中的抗病毒化疗——综述
Viruses. 2024 Apr 12;16(4):593. doi: 10.3390/v16040593.
10
Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future.用于对抗癌症的治疗性细菌和病毒:癌症治疗中的双刃剑:对未来的新见解
Cell Commun Signal. 2024 Apr 24;22(1):239. doi: 10.1186/s12964-024-01622-w.
Arch Acad Emerg Med. 2020 Mar 30;8(1):e40. eCollection 2020.
4
COVID-19 and Iran: swimming with hands tied!新冠疫情与伊朗:束手束脚!
Swiss Med Wkly. 2020 Apr 7;150:w20242. doi: 10.4414/smw.2020.20242. eCollection 2020 Apr 6.
5
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.美国食品药品监督管理局批准的药物伊维菌素可抑制 SARS-CoV-2 的体外复制。
Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
6
Potential therapeutic agents against COVID-19: What we know so far.针对 COVID-19 的潜在治疗药物:目前我们所了解的情况。
J Chin Med Assoc. 2020 Jun;83(6):534-536. doi: 10.1097/JCMA.0000000000000318.
7
Ivermectin Inhibits Bovine Herpesvirus 1 DNA Polymerase Nuclear Import and Interferes with Viral Replication.伊维菌素抑制牛疱疹病毒1型DNA聚合酶的核输入并干扰病毒复制。
Microorganisms. 2020 Mar 13;8(3):409. doi: 10.3390/microorganisms8030409.
8
Teicoplanin: an alternative drug for the treatment of COVID-19?替考拉宁:治疗 COVID-19 的一种替代药物?
Int J Antimicrob Agents. 2020 Apr;55(4):105944. doi: 10.1016/j.ijantimicag.2020.105944. Epub 2020 Mar 13.
9
The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer.广谱抗病毒药物伊维菌素靶向宿主核转运进口蛋白α/β1 异二聚体。
Antiviral Res. 2020 May;177:104760. doi: 10.1016/j.antiviral.2020.104760. Epub 2020 Mar 3.
10
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).世界卫生组织宣布全球紧急状态:对 2019 年新型冠状病毒(COVID-19)的回顾。
Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26.